A 65-Year-Old Man With a History AFib, Hypertension and Diabetes is Scheduled for Ablation

A 65-year-old man with a history of recurrent symptomatic paroxysmal atrial fibrillation (AF), hypertension, and diabetes is scheduled for AF ablation next week. The creatinine clearance is >60 and liver enzymes are normal. He has no prior history of liver disease, transient ischemic attack, stroke, coronary heart disease, or heart failure. He is currently anticoagulated with dabigatran 150mg twice daily, amlodipine, and flecainide. His cardiac echo shows normal size atria and ejection fraction of 58% with no significant valvular dysfunction.

Which of the following therapies is most appropriate for the patient's periprocedural anticoagulation?

Show Answer